Be the first to know

Never miss an update from iBio. Did you know that during reporting season, the announcements from NYSEMKT:IBIO often move the market?

iBio (NYSEMKT:IBIO) Company Logo

By joining StockLight, you agree to our Terms & Conditions and Privacy Policy
Create Alert Follow IBIO

iBio (IBIO)

US NYSEMKT:IBIO (94.9M)

0.88
+0.00 (0.09%)
10:04am EDT
LOADING
Loading price chart..

Summary

Current Price: $0.88
52w High/Low: $0.05 - 3.4
Market Cap: 94.9M
Price/Earnings: -0.61
Dividend Yield: -
Volume/Average: 1.6M - 39.7M
iBio (NYSEMKT:IBIO) Company Logo
iBio, Inc. is a biotechnology company, which engages in the development and manufacture of biotherapeutics... More
iBio (NYSEMKT:IBIO) Company Logo

iBio, Inc. is a biotechnology company, which engages in the development and manufacture of biotherapeutics. Its pipeline include idiopathic pulmonary fibrosis, systemic sclerosis, and scleroderma. It operates through the iBio, Inc. and iBio CDMO business segments. The company was founded on April 15, 1993 and is headquartered in New York, NY.

Annual Reports

iBio (IBIO) 10-K Annual Report Aug 26th 2019
2019
(808kb)
iBio (IBIO) 10-K Annual Report Sep 18th 2018
2018
(809kb)
iBio (IBIO) 10-K Annual Report Sep 15th 2017
2017
(710kb)
iBio (IBIO) 10-K Annual Report Oct 13th 2016
2016
(717kb)

Dividend History

No dividends found.

Quantitative Ratios

Stock Ratios Locked
You viewed 3 companies today
Ratios will be unlocked
again tomorrow or;

Unlock these ratios,
configure alerts
and much more...

Download StockLight

All Ratios, Alerts and other features are available in our iOS and Android apps:
Download on iOS Download on Android

We are working on updating this web app to fully enable Quantitative Ratios. All other current web features including annual reports, price sensitive announcements, dividends and earnings transcripts are free to use here on our web app.
Implied Growth
69.2%
 
187.5%
 
 
Industry Avg
IBIO

UNATTRACTIVE: iBio exhibits an implied growth ratio which exceeds the industry average for biotechnology stocks listed on the NYSEMKT. IBIO calculation: 10% - (-$1.47 / $0.88) = 177.0% more
Price / Sales
2.5
 
13.1
 
 
Industry Avg
IBIO

UNATTRACTIVE: iBio exhibits a price/sales ratio which exceeds the industry average for biotechnology stocks listed on the NYSEMKT. more

Company News

No company news found